Complete responses after neoadjuvant toripalimab and chemoradiotherapy for oesophageal squamous cell carcinoma: in situ and ex vivo 3.0 T MRI assessment

Br J Surg. 2024 Jan 3;111(1):znad363. doi: 10.1093/bjs/znad363.
No abstract available

MeSH terms

  • Chemoradiotherapy
  • Esophageal Neoplasms* / drug therapy
  • Esophageal Neoplasms* / therapy
  • Esophageal Squamous Cell Carcinoma* / diagnostic imaging
  • Esophageal Squamous Cell Carcinoma* / therapy
  • Esophagectomy
  • Humans
  • Magnetic Resonance Imaging
  • Neoadjuvant Therapy

Substances

  • toripalimab